Trials / Recruiting
RecruitingNCT07022496
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
Assessment of Oral Caffeine Intake in Reducing the Severity of Acute Migraine Attack Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals: A Randomized Controlled Trial
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Caffeine extracted from green tea to abort acute attack of Migraine
Detailed description
Caffeine tablets extracted from green tea can be used as caffeinated drinks to decrease intensity of migraine attacks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caffeine (200 mg) | caffeine tablets |
| DRUG | triptans | Sumatriptan |
| DRUG | NSAID (Nonsteroidal anti-inflammatory drugs) | Aspirin 250 mg, 81 mg, 75 mg |
| DRUG | Paracetamol (acetaminophen) | Paracetamol 250 mg |
Timeline
- Start date
- 2023-04-26
- Primary completion
- 2025-07-01
- Completion
- 2025-08-01
- First posted
- 2025-06-15
- Last updated
- 2025-06-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07022496. Inclusion in this directory is not an endorsement.